Ушбу иш иқтибос қилган ишлар

124 та иш

Иш: The role of microRNAs in modulating Wnt signaling pathway dynamics and their therapeutic implications in non-small cell lung cancer

MicroRNA as a Potential Therapeutic Molecule in Cancer
Joanna Szczepanek, Monika Skorupa, Andrzej Tretyn
Шарҳ мақола20225 иқтибос
ABI
Tumor Suppressor miRNA in Cancer Cells and the Tumor Microenvironment: Mechanism of Deregulation and Clinical Implications
Khalid Otmani, Philippe Lewalle
Шарҳ мақола20215 иқтибос
ABI
The Drosha-DGCR8 complex in primary microRNA processing
Jinju Han, Yoontae Lee, Kyu-Hyun Yeom +3
Мақола20044 иқтибос
ABI
Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
David S. Hong, Yoon‐Koo Kang, Mitesh J. Borad +20
Мақола20204 иқтибос
ABI
Noncoding RNA therapeutics — challenges and potential solutions
Melanie Winkle, Sherien M. El‐Daly, Muller Fabbri +1
Шарҳ мақола20214 иқтибос
ABI
miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis
Carmen Elena Condrat, Dana Claudia Thompson, Mădălina Gabriela Barbu +6
Шарҳ мақола20204 иқтибос
ABI
miRNA: A Promising Therapeutic Target in Cancer
Amrutha Menon, Noraini Abd-Aziz, Kanwal Khalid +2
Шарҳ мақола20224 иқтибос
ABI
Advancements in Biomaterials for Stem Cell Differentiation
Mingchen Shao, Mohamad Rahmdel, Sepideh Karkon Shayan +13
Шарҳ мақола20254 иқтибос
ABI
Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: New trends in the development of miRNA therapeutic strategies in oncology (Review)
Roberto Gambari, Eleonora Brognara, Demetrios�� Spandidos +1
Шарҳ мақола20163 иқтибос
ABI
Neurokinin-1 Receptor (NK-1R) Antagonists: Potential Targets in the Treatment of Glioblastoma Multiforme
Amir R. Afshari, Ali Motamed‐Sanaye, Hamed Sabri +7
Мақола20213 иқтибос
ABI
Trials and Tribulations of MicroRNA Therapeutics
Attila A. Seyhan
Мақола20243 иқтибос
ABI
NUTM2A-AS1 as a potential key regulator in cancer: unraveling its ceRNA networks and impact on tumor biology
Negar Taghavi Pourianazar, Safa Radmehr, Zahra Ourang +2
Шарҳ мақола20253 иқтибос
ABI
MiR-29a-3p: a potential biomarker and therapeutic target in colorectal cancer
Wenyan Mo, Shi-Qiong Cao
Шарҳ мақола20222 иқтибос
ABI
Mechanisms of immune checkpoint inhibitors: insights into the regulation of circular RNAS involved in cancer hallmarks
Lingjiao Meng, Haotian Wu, Jiaxiang Wu +4
Мақола20242 иқтибос
ABI
Wnt Signaling through Inhibition of β-Catenin Degradation in an Intact Axin1 Complex
Vivian Li, Ser Sue Ng, Paul J. Boersema +8
Мақола20122 иқтибос
ABI
MicroRNAs as biomarkers for early diagnosis, targeting and prognosis of prostate cancer
Alireza Azani, Sima Parvizi Omran, Haniyeh Ghasrsaz +14
Шарҳ мақола20232 иқтибос
ABI
Therapeutic Targeting of MicroRNAs in the Tumor Microenvironment
Rebecca Raue, Ann-Christin Frank, Shahzad N. Syed +1
Шарҳ мақола20212 иқтибос
ABI
From Molecular Mechanisms to Therapeutics: Understanding MicroRNA-21 in Cancer
Jiho Rhim, Woosun Baek, Yoona Seo +1
Шарҳ мақола20222 иқтибос
ABI
Wnt/β-catenin signaling in cancers and targeted therapies
Fanyuan Yu, Changhao Yu, Feifei Li +6
Шарҳ мақола20212 иқтибос
ABI
Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances
Xue Chen, Qingfei Chu, Qingmiao Shi +3
Шарҳ мақола20252 иқтибос
ABI
Targeting the Wnt/β-catenin signaling pathway in cancer
Ya Zhang, Xin Wang
Шарҳ мақола20202 иқтибос
ABI
Wnt signaling in colorectal cancer: pathogenic role and therapeutic target
Hui Zhao, Tianqi Ming, Shun Tang +5
Шарҳ мақола20222 иқтибос
ABI
Simultaneous overactivation of Wnt/β-catenin and TGFβ signalling by miR-128-3p confers chemoresistance-associated metastasis in NSCLC
Junchao Cai, Lishan Fang, Yongbo Huang +15
Мақола20172 иқтибос
ABI
MicroRNA in cancer therapy: breakthroughs and challenges in early clinical applications
Maria Teresa Di Martino, Pierosandro Tagliaferri, Pierfrancesco Tassone
Шарҳ мақола20252 иқтибос
ABI
Emerging concepts of miRNA therapeutics: from cells to clinic
Caroline Diener, Andreas Keller, Eckart Meese
Шарҳ мақола20222 иқтибос
ABI